PubMed (MeSH Keyword) for id: 6604413

Year	Number of Results
1979	5
1980	8
1981	14
1982	10
1983	20
1984	18
1985	11
1986	10
1987	3
1988	3
1989	1
1992	2
1993	1
1998	1
1999	1
2004	1
2012	1
2013	1
2019	1
2022	1
2024	0

1

Identification of hub genes associated with COVID-19 and idiopathic pulmonary fibrosis by integrated bioinformatics analysis.

Chen Q, Xia S, Sui H, Shi X, Huang B, Wang T. Chen Q, et al. PLoS One. 2022 Jan 19;17(1):e0262737. doi: 10.1371/journal.pone.0262737. eCollection 2022. PLoS One. 2022. PMID: 35045126 Free PMC article.

2

Identification of Off-Patent Compounds That Present Antifungal Activity Against the Emerging Fungal Pathogen Candida auris.

de Oliveira HC, Monteiro MC, Rossi SA, Pemán J, Ruiz-Gaitán A, Mendes-Giannini MJS, Mellado E, Zaragoza O. de Oliveira HC, et al. Front Cell Infect Microbiol. 2019 Apr 2;9:83. doi: 10.3389/fcimb.2019.00083. eCollection 2019. Front Cell Infect Microbiol. 2019. PMID: 31001487 Free PMC article.

3

A repurposing approach identifies off-patent drugs with fungicidal cryptococcal activity, a common structural chemotype, and pharmacological properties relevant to the treatment of cryptococcosis.

Butts A, DiDone L, Koselny K, Baxter BK, Chabrier-Rosello Y, Wellington M, Krysan DJ. Butts A, et al. Eukaryot Cell. 2013 Feb;12(2):278-87. doi: 10.1128/EC.00314-12. Epub 2012 Dec 14. Eukaryot Cell. 2013. PMID: 23243064 Free PMC article.

4

The effect of ischemia and pharmacological treatment evaluated on synaptosomes and purified mitochondria from rat cerebral cortex.

Villa RF, Benzi G, Curti D. Villa RF, et al. Biochem Pharmacol. 1981 Sep 1;30(17):2399-408. doi: 10.1016/0006-2952(81)90333-6. Biochem Pharmacol. 1981. PMID: 21043237

5

A screen for drugs that protect against the cytotoxicity of polyglutamine-expanded androgen receptor.

Piccioni F, Roman BR, Fischbeck KH, Taylor JP. Piccioni F, et al. Hum Mol Genet. 2004 Feb 15;13(4):437-46. doi: 10.1093/hmg/ddh045. Epub 2004 Jan 6. Hum Mol Genet. 2004. PMID: 14709594

6

Glucose- and K(+)-induced acidification in different yeast species.

Kotyk A, Lapathitis G, Krenková S. Kotyk A, et al. Folia Microbiol (Praha). 1999;44(3):295-8. doi: 10.1007/BF02818550. Folia Microbiol (Praha). 1999. PMID: 10664885

7

Different sources of acidity in glucose-elicited extracellular acidification in the yeast Saccharomyces cerevisiae.

Lapathitis G, Kotyk A. Lapathitis G, et al. Biochem Mol Biol Int. 1998 Dec;46(5):973-8. doi: 10.1080/15216549800204522. Biochem Mol Biol Int. 1998. PMID: 9861451

8

1H-NMR study of suloctidil-A23187 calcium ionophore interaction.

Chauvet-Monges AM, Faure R, Crevat A. Chauvet-Monges AM, et al. Chem Biol Interact. 1993 Feb;86(2):163-9. doi: 10.1016/0009-2797(93)90118-i. Chem Biol Interact. 1993. PMID: 8383582

9

Intermittent claudication: Suloctidil v.s. placebo treatment.

Holm J, Lindblad L, Scherstén T, Suurkula M. Holm J, et al. Vasa. 1984;13(2):175-8. Vasa. 1984. PMID: 6331019 Clinical Trial. No abstract available.

10

Hemodynamic-pharmacological effect on cerebral circulation evaluated by means of computerized CW Doppler signal spectrum analysis--first experiments on the action of Suloctidil.

De Fabritiis A, Guastarobba A, Scondotto G, Borgatti E. De Fabritiis A, et al. Monogr Neural Sci. 1984;11:243-50. doi: 10.1159/000409219. Monogr Neural Sci. 1984. PMID: 6330541 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

112 results

Results by year